1809 related articles for article (PubMed ID: 20442654)
1. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
2. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
Galach M; Utikal J
Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
[TBL] [Abstract][Full Text] [Related]
3. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
[TBL] [Abstract][Full Text] [Related]
4. Generation and genetic modification of induced pluripotent stem cells.
Schambach A; Cantz T; Baum C; Cathomen T
Expert Opin Biol Ther; 2010 Jul; 10(7):1089-103. PubMed ID: 20528610
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
6. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
7. New approaches for the generation of induced pluripotent stem cells.
Sidhu KS
Expert Opin Biol Ther; 2011 May; 11(5):569-79. PubMed ID: 21314494
[TBL] [Abstract][Full Text] [Related]
8. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
Romano G
Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
[TBL] [Abstract][Full Text] [Related]
9. Exploiting pluripotency for therapeutic gain.
Deng W
Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
[TBL] [Abstract][Full Text] [Related]
10. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
Das AK; Pal R
J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
[TBL] [Abstract][Full Text] [Related]
12. [An overview of pluripotent stem cell lines].
Kieffer E; Kuntz S; Viville S
Med Sci (Paris); 2010 Oct; 26(10):848-54. PubMed ID: 20929676
[TBL] [Abstract][Full Text] [Related]
13. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
14. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
Hussein SM; Nagy AA
Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation.
Jozefczuk J; Prigione A; Chavez L; Adjaye J
Stem Cells Dev; 2011 Jul; 20(7):1259-75. PubMed ID: 21162674
[TBL] [Abstract][Full Text] [Related]
16. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
[No Abstract] [Full Text] [Related]
17. Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.
Luzzani C; Solari C; Losino N; Ariel W; Romorini L; Bluguermann C; Sevlever G; Barañao L; Miriuka S; Guberman A
Biochem Biophys Res Commun; 2011 Jul; 410(4):816-22. PubMed ID: 21703227
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming adult hematopoietic cells.
Kaneko S; Otsu M; Nakauchi H
Curr Opin Hematol; 2010 Jul; 17(4):271-5. PubMed ID: 20571391
[TBL] [Abstract][Full Text] [Related]
19. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
Kang L; Kou Z; Zhang Y; Gao S
J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
